What Does IND Stand For?
IND stands for Investigational New Drug
IND, or Investigational New Drug, refers to a regulatory designation by the U.S. Food and Drug Administration (FDA) that allows a pharmaceutical company to begin clinical trials of a new drug. This designation is a critical step in the drug development process, as it involves submitting detailed information about the drug’s chemical composition, manufacturing process, and results from preclinical studies. An IND approval is essential for ensuring the safety and efficacy of a potential new therapy before it can be tested in humans.
Added on 27th September 2008 | Last edited on 16th June 2025 | Edit Acronym